Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Innate Pharma (IPHA) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Innate Pharma (IPHA) over the last 6 years, with Q2 2025 value amounting to 0.73.

  • Innate Pharma's Asset Utilization Ratio fell 9974.77% to 0.73 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.73, marking a year-over-year decrease of 9974.77%. This contributed to the annual value of 0.14 for FY2024, which is 5772.34% down from last year.
  • Per Innate Pharma's latest filing, its Asset Utilization Ratio stood at 0.73 for Q2 2025, which was down 9974.77% from 0.83 recorded in Q4 2024.
  • In the past 5 years, Innate Pharma's Asset Utilization Ratio registered a high of 288.29 during Q2 2024, and its lowest value of 0.06 during Q2 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.83 (2024), whereas its average is 108.35.
  • Per our database at Business Quant, Innate Pharma's Asset Utilization Ratio skyrocketed by 38482646.05% in 2023 and then plummeted by 9974.77% in 2025.
  • Quarter analysis of 5 years shows Innate Pharma's Asset Utilization Ratio stood at 0.27 in 2021, then skyrocketed by 72358.79% to 198.18 in 2022, then grew by 26.24% to 250.18 in 2023, then tumbled by 99.67% to 0.83 in 2024, then fell by 12.19% to 0.73 in 2025.
  • Its Asset Utilization Ratio stands at 0.73 for Q2 2025, versus 0.83 for Q4 2024 and 288.29 for Q2 2024.